Longitudinal metabolic observation of metformin effects during pregnancy in hyperinsulinemic women with polycystic ovary syndrome: A case report

Journal of Endocrinological Investigation

Volumn 27, Issue 1, 2004, Pages 70-75

  Guido, Maurizio ^a   Romualdi, D ^a   Belosi, C ^a   Selvaggi, L ^a   Lanzone, A ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b OASI RESEARCH INSTITUTE IRCCS   (Italy)

Author keywords

Diabetes; Insulin; Metformin; PCOS; Pregnancy

Indexed keywords

CLOMIFENE CITRATE; GLUCOSE; INSULIN; METFORMIN; MONOCOMPONENT INSULIN; NEUTRAL INSULIN; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL OBSERVATION; CONCEPTION; DELIVERY; DIARRHEA; DIET THERAPY; DRUG MECHANISM; FEMALE; GESTATION PERIOD; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HORMONAL REGULATION; HUMAN; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN SENSITIVITY; LONGITUDINAL STUDY; METABOLIC BALANCE; METABOLIC DISORDER; NAUSEA; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY DIABETES MELLITUS; PREGNANCY DISORDER; THIRD TRIMESTER PREGNANCY; TREATMENT FAILURE; TWIN PREGNANCY;

EID: 1542286075     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03350915     Document Type: Article

References (21)

1. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997, 18: 774-800.
2. Nestler JE, Stovall D, Akhter N, Iuorno MJ, Jakubowicz DJ. Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Fertil Steril 2002, 77: 209-15.
3. Lanzone A, Caruso A, Di Simone N, et al. Polycystic ovary syndrome. A risk factor for gestational diabetes? J Reprod Med 1995, 40: 312-6.
4. Lanzone A, Fulghesu AM, Cucinelli F, et al. Preconceptional and gestational evaluation of insulin secretion in patients with polycystic ovary syndrome. Hum Reprod 1996, 11: 2382-6.
5. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961, 21: 1440-7.
6. Fulghesu AM, Ciampelli M, Belosi C, Apa R, Pavone V, Lanzone A. A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio. Fertil Steril 2001, 76: 326-31.
7. Adams J, Polson DW, Abdulwahid N. Multifollicular ovaries: clinical and endocrine features and response to gonadotropin releasing hormone. Lancet 1985, 2: 1375-8.
8. New MI, Lorenzen F, Lerner AJ, et al. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab 1983, 57:320-6.
9. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979, 28: 1039-57.
10. Fulghesu AM, Cucinelli F, Pavone V, et al. Changes in luteinizing hormone and insulin secretion in polycystic ovary syndrome. Hum Reprod 1999, 14: 611-7.
11. Fulghesu AM, Apa R, Belosi C, et al. Recombinant versus urinary follicle-stimulating hormone in the low-dose regimen in anovulatory patients with polycystic ovary syndrome: a safer and more effective treatment. Horm Res 2001, 55: 224-8.
12. O'Sullivan JM, Mahan M. Criteria for the oral glucose tolerance test in pregnancy. Diabetes 1964, 13: 278-82.
13. Melczer Z, Bànhidy F, Csomor S, et al. Role of tumour necrosis factor-α in insulin resistance during normal pregnancy. Eur J Obstet Gynecol Reprod Biol 2002; 105:7-10.
14. Ciampelli M, Lanzone A, Caruso A. Insulin in obstetrics: a main parameter in the management of pregnancy. Hum Reprod Update 1998, 4: 904-14.
15. Sepe JS, Connel FA, Geiss LS, Teutsch MS. Incidence, maternal characteristics, and perinatal outcome. Diabetes 1985, 34: 13-6.
16. Catalano PM. Carbohydrate metabolism and gestational diabetes. Clin Obstet Gynecol 1994, 37: 25-38.
17. Paradisi G, Fulghesu AM, Ferrazzani S, et al. Endocrinometabolic features in women with polycystic ovary sindrome during pregnancy. Hum Reprod 1998, 13: 542-6.
18. Glueck CJ, Wang P, Kobayashi S, Phillips H, Sieve-Smith L. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril 2002, 77: 520-5.
19. Glueck CJ, Wang P, Goldenberg N, Sieve-Smith L. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod 2002, 17: 2858-64.
20. Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab 2002, 87: 524-9.
21. Elliot BD, Langer O, Schuessling F. Human placental glucose uptake and transport are not altered by the oral antihyperglycemic agent metformin. Am J Obstet Gynecol 1997, 176: 527-30